Akram W. Ibrahim 리트윗함

From the CABANA trial: Patients with #HFpEF benefited even more from #Afib ablation regarding:
🔸Death/CV 🏥
🔸AF recurrence
Despite the greater benefit for HFpEF pts, their risk of recurrence remained ⬆️ than in those w/out HFpEF
📎: jacc.org/doi/10.1016/j.… #JACCHF

English























